PDL BioPharma, Inc. (NASDAQ:PDLI) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive

PDL BioPharma, Inc. (NASDAQ:PDLI) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive

PDL BioPharma, Inc. (NASDAQ:PDLI) Files An 8-K Entry into a Material Definitive Agreement Item 1.01 Entry Into a Material Definitive Agreement.